|Page (1) of 1 - 08/11/17||email article||print page|
(August 11, 2017)
ROCKVILLE, Md., Aug. 11, 2017 /PRNewswire/ -- Market researcher Kalorama Information was featured in a New York Times article regarding the telemedicine market. The telemedicine market is 9.2 billion, according to Kalorama Information. The article, "Heart and Asthma Monitors? There's an App for That" used information from Kalorama Information's Remote Patient Monitoring Markets Remote Patient Monitoring & Telemedicine Market (Sleep, Diabetes, Vital Signs/EKG and Other Monitors) The report is available here: https://www.kaloramainformation.com/Advanced-Remote-Patient-10307860/.
"Telemedicine is a $9.2 billion business, said Kalorama Publisher Bruce Carlson in the story, publisher of Kalorama Information, a health care market-research firm in New York. The field is growing at 8 percent annually, nearly three times as fast as other medical devices."
Kalorama Information noted that the market for telemonitoring is growing as awareness of the benefits of the technology increases. And while it's still difficult to get payors to reimburse for every use of the technology, providers themselves are often paying for the equipment as it benefits their operations.
"It's in everyone's interest to cut hospital days," said Carlson. "And with nurse staff shortages in most U.S. regional markets, these technologies make sense for the provider even where unreimbursed. That being said, companies will want to obtain positive studies demonstrating benefits to improve their clout with payors."
The article covered a company named Eko Devices, one of many telehealth companies that has seen investor interest. The company, according to the article, raised nearly $5 million and sold 6,000 digital stethoscopes, used in 700 hospitals. They are marketing the Duo, a digital stethoscope for home use, which could change how heart patients are monitored, the entrepreneurs say. It is scheduled to become available by prescription in the fall. The product, the article said, combines electrocardiogram, or E.K.G., readings and heart sounds into a device that allows patients to monitor their health at home and send data to their physicians.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.
Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.
212 807 2262
View original content with multimedia:http://www.prnewswire.com/news-releases/kalorama-information-quoted-in-new-york-times-on-telemedicine-market-300503274.html
SOURCE Kalorama Information
Copyright 2014 PR Newswire. All Rights Reserved
Related Keywords:USA, Science, Medical Technology, Medical, Biology, Business, Other, Medical Professionals,
Related Sites: DMN Newswire , itbusinessnet.com , HTN - Health Technology Net
Related Newsletter: DMNForums , Tutorial Finder , Review Seeker , DMN Newswire Newsletter